A trial giving thousands of overweight Britons fat-busting jabs in a bid to get them back to work is now underway, officials have confirmed. Around 2.5million Britons are now thought to be having ...
Adults with type 1 diabetes using a continuous glucose monitoring system with a smart insulin pen attained a higher time in range if they responded more frequently to alerts for missed doses or high ...
Getting to grips with rising diabetes rates is arguably one of the most urgent tasks for South Africa's public healthcare system, but the setbacks keep coming. While some communities are facing ...
Health officials have repeatedly warned Britons against buying the jabs on social media and to be aware of scam online retailers posing as pharmacies.
Kids with type 1 diabetes and some kids with type 2 diabetes need to take insulin. Most kids who take insulin get injections using a syringe or a pre-filled pen. Some kids use an insulin pump instead.
Type 1 diabetes develops when the pancreas fails to produce enough insulin, a hormone made by specialized beta cells. This chronic condition affects an estimated 9.5 million people around the world.
The MarketWatch News Department was not involved in the creation of this content. SHANGHAI, Nov. 3, 2025 /PRNewswire/ -- A peer-reviewed article by researchers at the University of Shanghai for ...
SACRAMENTO – As the first and only state contracting for its own affordable insulin, Governor Gavin Newsom announced Oct. 16 that CalRx® biosimilar insulin glargine pens will be available to consumers ...
The state’s CalRx Insulin Glargine will be available to consumers for a suggested retail price of $55 or less per five-pack of pens beginning Jan. 1, 2026. The insulin glargine pen agreement with ...
California Governor Gavin Newsom today announced that CalRx® biosimilar insulin glargine pens will be available to consumers in California beginning January 1, 2026. This launch marks a significant ...
The new CalRx insulin will work as a generic version of glargine and could save patients $2000 to $4000 per year. HealthDay News — California will start selling low-cost insulin Jan. 1, nearly three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback